Concepedia

Marcelo Annes

MA

Statistics

Publications

6

Citations

988

H-Index

6

Active since

2008

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Fondazione IRCCS Istituto Neurologico Carlo Besta

International University of Health and Welfare

University of North Carolina at Chapel Hill

Stanford University

Marcelo Annes is an author at Alexion Pharmaceuticals (United States) specializing in medicine, myasthenia gravis, and pharmacotherapy.

Publications per year

2008–2020

6

Publications

6

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

, , +6

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

, , +9

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

, , +14

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

Hiroyuki Murai, Akiyuki Uzawa, Yasushi Suzuki et al. · Journal of the Neurological Sciences · 2019 · 23 citations · Full text

, , +14

Demyelinating disease in patients with myasthenia gravis

Denis Bernardi Bichuetti, Tatiane Martins de Barros, Enedina Maria Lobato de Oliveira et al. · Arquivos de Neuro-Psiquiatria · 2008 · 20 citations · Full text

, , +9

1–5 of 6